Nelarabine-associated rhabdomyolysis with severe creatine kinase elevation in a pediatric patient with T-cell acute lymphoblastic leukemia: a case report
Frontiers in Oncology · 05.08.2026 · 16
DOI: 10.3389/fonc.2026.1901440 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 05.08.2026. Verfasst von Fulden Aycan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stead Family Department of Pediatrics, Carver College of Medicine, The University of Iowa, Iowa City, IA, United States. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nelarabine is a purine nucleoside analog used in relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and in up-front pediatric therapy. Although neurologic toxicity is dose-limiting, skeletal muscle toxicity, including rhabdomyolysis, has been reported. Rhabdomyolysis occurred in approximately 2% of nelarabine-treated patients in pediatric COG AALL0434, although the clinical features of these events were not detailed. We report a 7-year-old patient with T-ALL who developed rapidly progressive diffuse myalgia, muscle stiffness, impaired ambulation, dark urine, presumptive myoglobinuria, and a peak creatine kinase (CK) level exceeding 70,000 U/L shortly after nelarabine administration during consolidation. Nelarabine was discontinued, and aggressive intravenous hydration led to complete clinical and biochemical recovery without acute kidney injury or renal replacement therapy. This case provides a detailed pediatric description of clinically overt nelarabine-associated rhabdomyolysis and emphasizes early recognition, renal-protective management, and CK monitoring in symptomatic patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stead Family Department of Pediatrics, Carver College of Medicine, The University of Iowa, Iowa City, IA, United States.
Zitieren
APA
Aycan, F., Spykerman, A. E., & Barnett, C. C. (2026). Nelarabine-associated rhabdomyolysis with severe creatine kinase elevation in a pediatric patient with T-cell acute lymphoblastic leukemia: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1901440
Vancouver
Aycan F, Spykerman AE, Barnett CC. Nelarabine-associated rhabdomyolysis with severe creatine kinase elevation in a pediatric patient with T-cell acute lymphoblastic leukemia: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1901440
BibTeX
@article{Aycan2026,
author = {Aycan, Fulden and Spykerman, Anna E and Barnett, Christopher Carter},
title = {Nelarabine-associated rhabdomyolysis with severe creatine kinase elevation in a pediatric patient with T-cell acute lymphoblastic leukemia: a case report},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1901440}
}
EUVIMED